BEACON THERAPEUTICS HOLDINGS LIMITED
BEACON THERAPEUTICS HOLDINGS LIMITED is a private limited company registered in the United Kingdom, under 14303840, incorporated on 18 August 2022. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 3 years. Registered office address: N7 9AS London, the United Kingdom. Formerly known as SPL 123 LIMITED. Directors include MR LANCE BALDO, MR CARIAD DIXON CHESTER, and MR KHUREM ARIF FAROOQ, and 6 others. Sole shareholder is Syncona Limited. Associated with 20 related entities, including BEACON THERAPEUTICS LIMITED, SYNCONA IP HOLDCO (2) LIMITED, and SYNCONA IP HOLDCO (3) LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
SPL 123 LIMITED
Registered Address
ROLLING STOCK YARD
188 YORK WAY
N7 9AS LONDON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Companies
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 14303840 | 2026-06-01 | open_in_new |